Volume 28, Issue 161 (6-2018)                   J Mazandaran Univ Med Sci 2018, 28(161): 166-184 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Meyfour A, Rezaei-Tavirani M. The Role of Omics in Clinical and Pharmaceutical Researches . J Mazandaran Univ Med Sci. 2018; 28 (161) :166-184
URL: http://jmums.mazums.ac.ir/article-1-10440-en.html
Abstract:   (1830 Views)
Completion of the human genome project revealed that the molecular mechanisms of cellular responses to different situations cannot be predicted from the sequence of their genes. Hence, most biological researches are focused on the roles of proteins which are much more challenging tasks. Omics technologies, instead of analyzing individual components of an organism by conventional biochemical methods such as the function of a gene, protein or biochemical reaction, study all the components and their interactions within a global site. In the past two decades, omics technologies have been used as efficient and powerful tools in almost all aspects of clinical and pharmaceutical researches, including biomarker discovery, drug target discovery, evaluation of the efficacy of drugs, safety assessment, and personalized medicine. In this article, omics technologies such as genomics, transcriptomics, proteomics and metabolomics, and their advances are reviewed and their applications in clinical and pharmaceutical researches, particularly in the areas of drug targets, biomarkers, and personalized medicine are discussed.

Full-Text [PDF 738 kb]   (475 Downloads)    
Type of Study: Review | Subject: Biology

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb